Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of April 5 Dividend Increases/Decreases for the Week of March 29 Dividend Increases/Decreases for the Week of March 22 Dividend Increases/Decreases for the Week of March 15 Dividend Increases/Decreases for the Week of March 8

Results 1 - 10 of 201 for hum. (0.30 seconds) Inside the New Abbott: A Lot Like the Old Abbott But Without Humira We take a dive inside the prospects of the... AbbVie’s Humira Continues to Drive Strong Performance; Pipeline Advances Humira continues to drive strong... Coherus Biosciences Begins the Process of Bringing a Humira Biosimilar to Market Image Source: Drugs.com. The duration and validity of... Earnings Roundup: V, INTC, HUM, PYPL Image: Visa’s operating margins are phenomenal.... Value Is Not Static and the Qualitative Overlay Is Vital to Our Process With prudence and care, the Valuentum Buying Index... Best in Biotech? Global Blood Therapeutics' Promising Treatment for Sickle Cell Anemia Image Source: National Institute for Health. We... 5 Years Strong! Image Source: Andy Maguire. So much to say...... Is AbbVie a Value Trap? Image Source: Express Scripts. With uncertainty... Big Pharma, Big Dividends: Earnings Update Featuring Eli Lilly, Bristol-Myers Squibb, and AbbVie Image Source: Drugs.com. Let’s dive into some... Merck’s Dominance in Immuno-Oncology Expands Once Again Image Source: Merck. Merck simply blew away the... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next